Use este identificador para citar ou linkar para este item: http://repositorio.ufc.br/handle/riufc/7152
Tipo: Artigo de Periódico
Título: Drug interactions in Brazilian type 2 diabetes patients
Autor(es): Araújo, Márcio Flávio Moura de
Alves, Priscila de Jesus dos Santos
Veras, Vivian Saraiva
Araújo, Thiago Moura de
Zanetti, Maria Lúcia
Damasceno, Marta Maria Coelho
Palavras-chave: Anti-Hipertensivos;Glucose;Hipoglicemiantes
Data do documento: Ago-2013
Instituição/Editor/Publicador: International Journal of Nursing Practice
Citação: ARAÚJO, M. F. M. Drug interactions in Brazilian type 2 diabetes patients. International Journal of Nursing Practice, v. 19, n. 4, p. 423-430, ago. 2013.
Abstract: The aim of this paper is to identify the prevalence of the most frequent drug interactions in patients using oral antidiabéticos and their association with capillary glucose and medication adherence. In total, 579 type 2 diabetes mellitus patients from 12 health institutions in Fortaleza, Brazil were interviewed in 2009. A form was applied, including questions on medication use, comorbidities, lifestyle, body mass index and random capillary glucose. Results revealed that 26.7% used five or more different drugs simultaneously and daily. Statistically significant drug interactions occurred between antidiabéticos and diuretics, angiotensin-converting enzyme inhibitors, anti-lipidaemics and corticoids. No significant association was found between polypharmacy, medication adherence and glucose. It is important for nurses, in consensus with other health professionals, to consider the possibility of other drugs that mean less risk for diabetes patients’ glucose control or of increased antidiabetics doses.
URI: http://www.repositorio.ufc.br/handle/riufc/7152
ISSN: 1440-172X Online
Aparece nas coleções:DENF - Artigos publicados em revistas científicas

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
2013_art_mfmaraujo1.pdf121,73 kBAdobe PDFVisualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.